Francesca Buttigieg is Director, Regulatory Affairs, PTC Therapeutics Inc., Switzerland. She is an experienced Regulatory Affairs Director with a demonstrated history of working in the pharmaceutical industry, and is skilled in Global Drug Development, Regulatory Requirements and Regulatory Strategy.
Greg Perry, Assistant Director General, discussed in this year’s annual lecture, learnings on the IFPMA and the impact of the COVID-19 pandemic on Africa. In particular, the importance of building a strong infrastructure within the continent, in relation to the establishment of the AMA.
Following last year’s success, Daniela Drago, Carlos Langezaal and Fortunato Fred Senatore were back to conduct another interactive session. Attendees gathered into groups to discuss and propose regulatory strategies based on a number of scenarios, three of which will be described here.